Lumanity Value, Access & Outcomes’ Post

Thinking about your next career move? Check out current openings at Lumanity! Whether you’re an experienced professional or a recent graduate, join Lumanity to make a difference. We are a collaborative, global team—no matter where you live, you can help us build a healthier world. View all available positions at: https://buff.ly/3W0ZSUc #healthcarecareers #healtheconomics #outcomesresearch #marketaccess #HEOR

Through incisive thinking and decisive action, our team of experts cut through complexity and deliver transformative outcomes to accelerate and optimize access to medical advances. Want to find out more? Visit our website https://lumanity.com/. #HEOR #HealthEconomics #HTA #MarketAccess #PatientCenteredOutcomes

Advanced Therapy Medicinal Products (ATMPs) which include CAR T-cell therapies, will be some of the first products to undergo assessment through the new EU HTA Regulation process from January 2025. Understanding the evidence requirements and implications on decision outcomes is imperative for future reimbursement success in Europe. Discover additional insights on CAR T-cell reimbursement in the US, UK and EU4 in our whitepaper: https://buff.ly/4eFtDkM #LumanityPerspectives #HEOR #Oncology #Reimbursement #EUHTARegulation

New research from our partners highlighting the importance of coordination between general practitioners (GPs) and obstetricians/gynecologists in the provision of routine medical care during pregnancy. Read the full research brief in English at https://lnkd.in/eq7SVzgj or in Dutch at https://lnkd.in/eh-9pwig   #realworldevidence #realworlddata #carecoordination #drugsafety #adversevent #adverseventmonitoring #pharmacovigilance #teratogenic #riskmanagement #publichealth

Thinking about your next career move? Check out current openings at Lumanity! Whether you’re an experienced professional or a recent graduate, join Lumanity to make a difference. We are a collaborative, global team—no matter where you live, you can help us build a healthier world. View all available positions at: https://buff.ly/3xJqBLx #healthcarecareers #healtheconomics #outcomesresearch #marketaccess #HEOR

At Lumanity we offer training on a variety of topics including economic modelling, survival analyses and comparative efficacy. Our experts create training with the end user in mind, creating content focused on the what, why and how. Our team has a wealth of experience. Listed below are just some of training sessions we have to offer: - Practical coding workshops, where we can walk you through the application of methods and provide hands on support. - NICE methods updates and the implications for manufacturers looking to bring products to the UK market - Company representation at NICE and SMC meetings - The new EU HTA Regulation and its implications for manufacturers Contact us through our website and one of our experts would be happy to talk you through our training offerings. https://buff.ly/3zvoewn #HealthEconomics #HEORTraining #Training

In our article we use an interactive map to summarize the self-reported key challenges, opportunities and readiness scores for each Member State as we get closer to the EU HTA Regulation’s first implementation phase. The article also explores what delays in the majority of the implementation acts for the EU HTA Regulation will mean for industry participants trying to prepare for the Regulation’s impact. Read the article below and contact us to find out how we can help you to prepare. https://buff.ly/4eJtQTS #LumanityPerspectives #EUHTA Regulation #HEOR #HTA

Did you miss our April webinar exploring the Inflation Reduction Act (IRA) and EU Joint Clinical Assessment (JCA)? The IRA and EU JCA are two of the most seismic changes to the value and access landscape in a generation and require careful planning and consideration by manufacturers to navigate them successfully. Watch the recording of our webinar here and contact us if we can be of any assistance: https://buff.ly/3zdM0gj. #LumanityPerspectives #InflationReductionAct #IRA #EUHTARegulation #EUHTA #JCA #HEOR

The path to market for new medical technology can be challenging, and keeping up with the ever evolving pharmaceutical and biotech landscape is vital for success. Our experts are leaders in developing new solutions and understanding how changes like the new EU HTA Regulation and US Inflation Reduction Act will impact our clients. We understand the complex path to the market, and we regularly share our insights and can offer bespoke training to your teams. Visit the perspectives page on our website to read our latest insights and find out how we can illuminate the path to market for your health technology. https://buff.ly/4cjcmfs #HEOR #Pharma #Biotech #HTA

Our Value, Access & Outcomes experts can help you unlock the full potential of your products and demonstrate their value to stakeholders around the world. Visit our website and find out why our clients choose Lumanity as their pharmaceutical Market Access and HEOR partner. https://lumanity.com/ #HealthEconomics #OutcomesResearch #HEOR #MarketAccess